Event
Course Description:
This webinar series will update you on the latest USP developments in Particulate Matters.
The series will focus on USP General Chapters <1>, <790> and <1790>, which address particles observed in injections in the visible range. Specific methods and requirements will be reviewed and compared with similar expectations found in the European and Japanese Pharmacopeias. Also included is a discussion about the recently released draft guidance from FDA titled Inspection of Injectable Products for Visible Particles.
Who should participate:
- Laboratory scientists
- Lab managers
- QA/QC staff in the pharmaceutical and allied industries
- Regulatory professionals
- Scientists with interest in Particulate Matter